Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

Laura E. Targownik; Eric I. Benchimol; Charles N. Bernstein; Harminder Singh; Aruni Tennakoon; Antonio Aviña Zubieta; Stephanie Coward; Jennifer Jones; Gilaad G. Kaplan; M. Ellen Kuenzig; Sanjay K. Murthy; Geoffrey C. Nguyen; Juan Nicolás Peña-Sánchez

doi:10.1093/ecco-jcc/jjaa050

Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

Laura E. Targownik, Eric I. Benchimol, Charles N. Bernstein, Harminder Singh, Aruni Tennakoon, Antonio Aviña Zubieta, Stephanie Coward, Jennifer Jones, Gilaad G. Kaplan, M. Ellen Kuenzig, Sanjay K. Murthy, Geoffrey C. Nguyen, Juan Nicolás Peña-Sánchez

Business, Management and Accounting

Research output: Contribution to journal › Article › peer-review

50 Citations (Scopus)

Original language	English
Pages (from-to)	1354-1363
Number of pages	10
Journal	Journal of Crohn's and Colitis
Volume	14
Issue number	10
DOIs	https://doi.org/10.1093/ecco-jcc/jjaa050
Publication status	Published - Oct 1 2020

ASJC Scopus Subject Areas

Gastroenterology

Access to Document

10.1093/ecco-jcc/jjaa050

Cite this

Targownik, L. E., Benchimol, E. I., Bernstein, C. N., Singh, H., Tennakoon, A., Zubieta, A. A., Coward, S., Jones, J., Kaplan, G. G., Kuenzig, M. E., Murthy, S. K., Nguyen, G. C., & Peña-Sánchez, J. N. (2020). Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications. Journal of Crohn's and Colitis, 14(10), 1354-1363. https://doi.org/10.1093/ecco-jcc/jjaa050

Targownik, LE, Benchimol, EI, Bernstein, CN, Singh, H, Tennakoon, A, Zubieta, AA, Coward, S, Jones, J, Kaplan, GG, Kuenzig, ME, Murthy, SK, Nguyen, GC & Peña-Sánchez, JN 2020, 'Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications', Journal of Crohn's and Colitis, vol. 14, no. 10, pp. 1354-1363. https://doi.org/10.1093/ecco-jcc/jjaa050

@article{22fc9d27d9a2434094c49596a701ccf2,

title = "Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications",

author = "Targownik, {Laura E.} and Benchimol, {Eric I.} and Bernstein, {Charles N.} and Harminder Singh and Aruni Tennakoon and Zubieta, {Antonio Avi{\~n}a} and Stephanie Coward and Jennifer Jones and Kaplan, {Gilaad G.} and Kuenzig, {M. Ellen} and Murthy, {Sanjay K.} and Nguyen, {Geoffrey C.} and Pe{\~n}a-S{\'a}nchez, {Juan Nicol{\'a}s}",

note = "Funding Information: This work was supported through a grant from the Crohn's and Colitis Canada Grants in Aid of Research and the Helmsley Foundation. Publisher Copyright: {\textcopyright} 2020 The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn's and Colitis Organisation. All rights reserved.",

year = "2020",

month = oct,

day = "1",

doi = "10.1093/ecco-jcc/jjaa050",

language = "English",

volume = "14",

pages = "1354--1363",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

AU - Targownik, Laura E.

AU - Benchimol, Eric I.

AU - Bernstein, Charles N.

AU - Singh, Harminder

AU - Tennakoon, Aruni

AU - Zubieta, Antonio Aviña

AU - Coward, Stephanie

AU - Jones, Jennifer

AU - Kaplan, Gilaad G.

AU - Kuenzig, M. Ellen

AU - Murthy, Sanjay K.

AU - Nguyen, Geoffrey C.

AU - Peña-Sánchez, Juan Nicolás

N1 - Funding Information: This work was supported through a grant from the Crohn's and Colitis Canada Grants in Aid of Research and the Helmsley Foundation. Publisher Copyright: © 2020 The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn's and Colitis Organisation. All rights reserved.

PY - 2020/10/1

Y1 - 2020/10/1

UR - http://www.scopus.com/inward/record.url?scp=85092680134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092680134&partnerID=8YFLogxK

U2 - 10.1093/ecco-jcc/jjaa050

DO - 10.1093/ecco-jcc/jjaa050

M3 - Article

C2 - 32648579

AN - SCOPUS:85092680134

SN - 1873-9946

VL - 14

SP - 1354

EP - 1363

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - 10

ER -

Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this